Stock Research for BIIB

BIIB

Featured Broker: Ally Invest

Get the due diligence for another stock.

 

BIIB Stock Chart & Research Data

The BIIB chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the BIIB chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


BIIB Due diligence Resources & Stock Charts

The BIIB stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View BIIB Detailed Price Forecast - CNN Money CNN View BIIB Detailed Summary - Google Finance
Yahoo View BIIB Detailed Summary - Yahoo! Finance Zacks View BIIB Stock Research & Analysis - Zacks.com

Stock Analysis

TradeIdeas View BIIB Trends & Analysis - Trade-Ideas Barrons View BIIB Major Holders - Barrons
NASDAQ View BIIB Call Transcripts - NASDAQ Seeking View BIIB Breaking News & Analysis - Seeking Alpha
Spotlight View BIIB Annual Report - CompanySpotlight.com OTC Report View BIIB OTC Short Report - OTCShortReport.com
TradeKing View BIIB Fundamentals - TradeKing Charts View BIIB SEC Filings - Bar Chart
WSJ View Historical Prices for BIIB - The WSJ Morningstar View Performance/Total Return for BIIB - Morningstar
MarketWatch View the Analyst Estimates for BIIB - MarketWatch CNBC View the Earnings History for BIIB - CNBC
StockMarketWatch View the BIIB Earnings - StockMarketWatch MacroAxis View BIIB Buy or Sell Recommendations - MacroAxis
Bullish View the BIIB Bullish Patterns - American Bulls Short Pains View BIIB Short Pain Metrics - ShortPainBot.com

Social Media Mentions

StockTwits View BIIB Stock Mentions - StockTwits PennyStocks View BIIB Stock Mentions - PennyStockTweets
Twitter View BIIB Stock Mentions - Twitter Invest Hub View BIIB Investment Forum News - Investor Hub
Yahoo View BIIB Stock Mentions - Yahoo! Message Board Seeking Alpha View BIIB Stock Mentions - Seeking Alpha


Financial & Transaction Holdings

SECform4 View Insider Transactions for BIIB - SECform4.com Insider Cow View Insider Transactions for BIIB - Insider Cow
CNBC View BIIB Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for BIIB - OTC Markets
Yahoo View Insider Transactions for BIIB - Yahoo! Finance NASDAQ View Institutional Holdings for BIIB - NASDAQ


Stock Charts

FinViz View BIIB Stock Insight & Charts - FinViz.com StockCharts View BIIB Investment Charts - StockCharts.com
BarChart View BIIB Stock Overview & Charts - BarChart Trading View View BIIB User Generated Charts - Trading View




Latest Financial News for BIIB


Sell-Side Roundup: What's Next For For Applied Genetic After 50% Plunge?
Posted on Thursday December 13, 2018

Applied Genetic Technologies Corp (NASDAQ: AGTC ), a biotech focused on adeno-associated virus-based gene therapies for the treatment of rare diseases, reported disappointing results from an X-linked retinoschisis ...


Taking Stock of Biogen’s Recent Performance
Posted on Thursday December 13, 2018

Biogen’s (BIIB) core growth areas include multiple sclerosis and neuroimmunology, Alzheimer’s disease and dementia, movement disorders, and neuromuscular disorders. It’s also focused on areas such as pain, ophthalmology, neuropsychiatry, and acute neurology.


A Closer Look at Biogen’s Gross Margin Trends
Posted on Thursday December 13, 2018

In 2018 and 2019, Biogen (BIIB) is expected to generate revenues of $13.31 billion and $13.66 billion, respectively, compared to $12.27 billion in 2017.


The Zacks Analyst Blog Highlights: Gilead Sciences, Conatus Pharmaceuticals, Biogen, Ionis Pharmaceuticals and Exelixis
Posted on Thursday December 13, 2018

The Zacks Analyst Blog Highlights: Gilead Sciences, Conatus Pharmaceuticals, Biogen, Ionis Pharmaceuticals and Exelixis


Stock Market & Investing Books

Enter a stock symbol to view the stock details.